In the 15 years since Stuart Grant and Jay Eisenhofer started their own law firm, Grant & Eisenhofer has grown from four attorneys to almost 75 in three offices. But the firm never lost focus on its goal, Grant said to serve the needs of institutional investors. “We had seen at the time that the corporate defense bar was well represented,” he said. “Institutional investors had a lot of money invested and yet nobody was representing them.”
During the past year the Wilmington, Del.-based firm represented the lead whistleblower in the government’s False Claims Act case against Abbott Laboratories. That $1.6 billion settlement, announced in May, involved alleged illegal marketing of the anti-seizure drug Depakote to children and geriatric patients.
